• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸部介入肿瘤学的进展:经动脉化疗栓塞及相关治疗

Advancements in Interventional Oncology of the Chest: Transarterial Chemoembolization and Related Therapies.

作者信息

Lorenz Jonathan M, Navuluri Rakesh

机构信息

Department of Radiology, The University of Chicago Medical Center, Chicago, Illinois.

出版信息

Semin Intervent Radiol. 2022 Aug 31;39(3):253-260. doi: 10.1055/s-0042-1751259. eCollection 2022 Jun.

DOI:10.1055/s-0042-1751259
PMID:36062230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9433158/
Abstract

While embolization therapy has been used for many years in the treatment of nonmalignant diseases of the chest, such as pulmonary arteriovenous malformation treatment and bronchial artery embolization for hemorrhage, the application of transarterial techniques to the treatment of chest neoplasms is relatively uncommon. Extrapolating from transarterial chemoembolization techniques used for liver malignancy, investigators have recently sought to expand the indications for transarterial techniques from the control of symptoms such as bleeding to the control of disease progression and potentially survival benefit in patients with malignancies in the chest. This article provides an overview of the current embolotherapy techniques used in the treatment of patients with thoracic malignancies.

摘要

虽然栓塞疗法多年来一直用于治疗胸部非恶性疾病,如肺动静脉畸形的治疗和支气管动脉栓塞治疗出血,但经动脉技术在胸部肿瘤治疗中的应用相对少见。从用于治疗肝脏恶性肿瘤的经动脉化疗栓塞技术推断,研究人员最近试图将经动脉技术的适应证从控制出血等症状扩大到控制疾病进展,并可能使胸部恶性肿瘤患者受益于生存。本文概述了目前用于治疗胸部恶性肿瘤患者的栓塞治疗技术。

相似文献

1
Advancements in Interventional Oncology of the Chest: Transarterial Chemoembolization and Related Therapies.胸部介入肿瘤学的进展:经动脉化疗栓塞及相关治疗
Semin Intervent Radiol. 2022 Aug 31;39(3):253-260. doi: 10.1055/s-0042-1751259. eCollection 2022 Jun.
2
Embolization of Chest Neoplasms: The Next Frontier in Interventional Oncology?胸部肿瘤的栓塞治疗:介入肿瘤学的下一个前沿领域?
Semin Intervent Radiol. 2019 Aug;36(3):176-182. doi: 10.1055/s-0039-1692658. Epub 2019 Aug 19.
3
Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy.介入肿瘤学:优化经动脉治疗以治疗肝脏恶性肿瘤
Tech Vasc Interv Radiol. 2018 Dec;21(4):205-222. doi: 10.1053/j.tvir.2018.07.002. Epub 2018 Jul 31.
4
Role of interventional radiology in managing pediatric liver tumors : Part 1: Endovascular interventions.介入放射学在小儿肝脏肿瘤治疗中的作用:第1部分:血管内介入治疗
Pediatr Radiol. 2018 Apr;48(4):555-564. doi: 10.1007/s00247-018-4068-1. Epub 2018 Jan 23.
5
Role of Interventional Radiology in Pediatric Cancer Patients.介入放射学在儿科癌症患者中的作用。
Curr Oncol Rep. 2022 Dec;24(12):1731-1740. doi: 10.1007/s11912-022-01320-1. Epub 2022 Sep 3.
6
Noncontrast chest computed tomography immediately after transarterial chemoembolization in patients with hepatocellular carcinoma: clinical benefits and effect of radiation reduction on image quality in low-dose scanning.肝细胞癌患者经动脉化疗栓塞术后立即行非增强胸部 CT 检查:临床获益及低剂量扫描时降低辐射对图像质量的影响。
Eur J Radiol. 2011 Nov;80(2):e188-94. doi: 10.1016/j.ejrad.2011.06.009. Epub 2011 Jun 25.
7
Hepatic embolotherapy in interventional oncology: technology, techniques, and applications.介入肿瘤学中的肝栓塞治疗:技术、技术和应用。
Clin Radiol. 2013 Jan;68(1):1-15. doi: 10.1016/j.crad.2012.06.112. Epub 2012 Aug 20.
8
Intraarterial Therapies for the Management of Hepatocellular Carcinoma.用于肝细胞癌治疗的动脉内疗法
Cancers (Basel). 2022 Jul 10;14(14):3351. doi: 10.3390/cancers14143351.
9
Interventional radiology in oncology: clinical management of patients undergoing transarterial chemoembolization for hepatic malignancies.肿瘤介入放射学:肝恶性肿瘤经动脉化疗栓塞术患者的临床管理
Clin J Oncol Nurs. 2012 Feb;16(1):83-5. doi: 10.1188/12.CJON.83-85.
10
HCC: Transarterial Therapies-What the Interventional Radiologist Can Offer.HCC:经动脉治疗——介入放射学家的治疗方案。
Dig Dis Sci. 2019 Apr;64(4):959-967. doi: 10.1007/s10620-019-05542-5.

引用本文的文献

1
Drug-eluting beads bronchial arterial chemoembolization vs. conventional bronchial arterial chemoembolization in the treatment of advanced non-small cell lung cancer.载药微球支气管动脉化疗栓塞术与传统支气管动脉化疗栓塞术治疗晚期非小细胞肺癌的对比研究
Front Med (Lausanne). 2023 Aug 3;10:1201468. doi: 10.3389/fmed.2023.1201468. eCollection 2023.

本文引用的文献

1
Efficacy and Safety of Drug-Eluting Bead Bronchial Arterial Chemoembolization Plus Anlotinib in Patients With Advanced Non-small-Cell Lung Cancer.药物洗脱微球支气管动脉化疗栓塞术联合安罗替尼治疗晚期非小细胞肺癌的疗效与安全性
Front Cell Dev Biol. 2021 Oct 29;9:768943. doi: 10.3389/fcell.2021.768943. eCollection 2021.
2
Transcatheter arterial chemoembolization improves clinical efficacy and life quality of patients with lung cancer and reduces adverse reactions.经导管动脉化疗栓塞术提高了肺癌患者的临床疗效和生活质量,并减少了不良反应。
Am J Transl Res. 2021 Sep 15;13(9):10396-10403. eCollection 2021.
3
Sintilimab plus Bronchial Arterial Infusion Chemotherapy/Drug-Eluting Embolic Chemoembolization for Advanced Non-Small Cell Lung Cancer: A Preliminary Study of 10 Patients.信迪利单抗联合支气管动脉灌注化疗/载药微球栓塞化疗治疗晚期非小细胞肺癌:10 例初步研究。
J Vasc Interv Radiol. 2021 Dec;32(12):1679-1687. doi: 10.1016/j.jvir.2021.08.019. Epub 2021 Sep 4.
4
Bronchial or Pulmonary Artery Chemoembolization for Unresectable and Unablatable Lung Metastases: A Phase I Clinical Trial.不可切除和不可消融肺部转移瘤的支气管动脉或肺动脉化疗栓塞:I 期临床试验。
Radiology. 2021 Nov;301(2):474-484. doi: 10.1148/radiol.2021210213. Epub 2021 Aug 31.
5
Drug-Eluting Beads Bronchial Arterial Chemoembolization in Treating Relapsed/Refractory Small Cell Lung Cancer Patients: Results from a Pilot Study.药物洗脱微球支气管动脉化疗栓塞术治疗复发/难治性小细胞肺癌患者:一项前瞻性研究的结果
Cancer Manag Res. 2021 Aug 7;13:6239-6248. doi: 10.2147/CMAR.S310115. eCollection 2021.
6
Drug-eluting beads bronchial arterial chemoembolization plus intercostals arterial infusion chemotherapy is effective and well-tolerated in treating non-small cell lung cancer patients with refractory malignant pleural effusion.载药微球支气管动脉化疗栓塞术联合肋间动脉灌注化疗治疗难治性恶性胸腔积液的非小细胞肺癌患者疗效显著且耐受性良好。
J Thorac Dis. 2021 Apr;13(4):2339-2350. doi: 10.21037/jtd-20-1603.
7
Drug-eluting bead bronchial arterial chemoembolization vs. chemotherapy in treating advanced non-small cell lung cancer: comparison of treatment efficacy, safety and quality of life.载药微球支气管动脉化疗栓塞与化疗治疗晚期非小细胞肺癌的疗效、安全性及生活质量比较。
Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2554-2566. doi: 10.26355/eurrev_202103_25419.
8
Pirarubicin-loaded CalliSpheres® drug-eluting beads for the treatment of patients with stage III-IV lung cancer.载有吡柔比星的CalliSpheres®药物洗脱微球用于治疗III-IV期肺癌患者。
Acta Radiol. 2022 Mar;63(3):311-318. doi: 10.1177/0284185121994298. Epub 2021 Feb 20.
9
Combination of computed tomography-guided iodine-125 brachytherapy and bronchial arterial chemoembolization for locally advanced stage III non-small cell lung cancer after failure of concurrent chemoradiotherapy.CT 引导下碘 125 放射性粒子植入与支气管动脉化疗栓塞联合治疗同步放化疗失败后局部晚期Ⅲ期非小细胞肺癌
Lung Cancer. 2020 Aug;146:290-296. doi: 10.1016/j.lungcan.2020.06.010. Epub 2020 Jun 20.
10
Clinical effect of bronchial arterial infusion chemotherapy and CalliSpheres drug-eluting beads in patients with stage II-IV lung cancer: A prospective cohort study.支气管动脉灌注化疗与 CalliSpheres 载药微球在 II-IV 期肺癌患者中的临床疗效:一项前瞻性队列研究。
Thorac Cancer. 2020 Aug;11(8):2155-2162. doi: 10.1111/1759-7714.13522. Epub 2020 Jun 30.